Apr 2023 |
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel |
Biomedicines |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
Apr 2023 |
Immunization with a small fragment of the Schmallenberg virus nucleoprotein highly conserved across the Orthobunyaviruses of the Simbu serogroup reduces viremia in SBV challenged IFNAR-/- mice |
Vaccine |
Research funded by EVAg, Published by EVAg partner |
Mar 2023 |
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants |
iScience |
Research funded by EVAg, Published by EVAg partner |
Mar 2023 |
Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial |
eClinicalMedicine |
Research funded by EVAg, Published by EVAg end-user |
Feb 2022 |
Multilateral benefit-sharing from digital sequence information will support both science and biodiversity conservation |
Nature Communications |
Research funded by EVAg, Published by EVAg partner |
Jan 2022 |
The Petasites hybridus CO2 Extract (Ze 339) Blocks SARS-CoV-2 Replication In Vitro |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Jan 2022 |
First report of Tradescantia mild mosaic virus infecting Tradescantia × andersoniana in Germany |
New Disease Reports |
Research funded by EVAg, Published by EVAg partner |
Jan 2022 |
Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor |
Sensors & Diagnostics |
Research funded by EVAg, Published by EVAg partner |
Dec 2021 |
Complementary methods for SARS-CoV-2 diagnosis in times of material shortage |
Scientific Reports |
Research funded by EVAg, Published by EVAg end-user |
Dec 2021 |
Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions |
Scientific Reports |
Research funded by EVAg, Published by EVAg end-user |
Dec 2021 |
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection |
Nature Communications |
Research funded by EVAg, Published by EVAg end-user |
Dec 2021 |
Multiplex-RT-PCR-ELISA panel for detecting mosquito-borne pathogens: Plasmodium sp. preserved and eluted from dried blood spots on sample cards |
Malaria Journal |
Research funded by EVAg, Published by EVAg end-user |
Dec 2021 |
A novel and sensitive real-time PCR system for universal detection of poxviruses |
Scientific Reports |
Research funded by EVAg, Published by EVAg partner |
Dec 2021 |
Determination of the characteristic inactivation fluence for SARS-CoV-2 under UV-C radiation considering light absorption in culture media |
Scientific Reports |
Research funded by EVAg, Published by EVAg end-user |
Dec 2021 |
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model |
Nature Communications |
Research funded by EVAg, Published by EVAg partner |
Nov 2021 |
Evaluation of formulations to improve SARS-CoV-2 viability and thermostability after lyophilisation |
Journal of Virological Methods |
Research funded by EVAg, Published by EVAg partner |
Sep 2021 |
Inactivation of SARS-CoV-2 by Simulated Sunlight on Contaminated Surfaces |
Microbiology Spectrum |
Research funded by EVAg, Published by EVAg end-user |
Sep 2021 |
Transmission of SARS-CoV-2 from Human to Domestic Ferret |
Emerging Infectious Diseases |
Research funded by EVAg, Published by EVAg partner |
Sep 2021 |
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2 |
Antiviral Research |
Research funded by EVAg, Published by EVAg partner |
Aug 2021 |
Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan |
PLoS ONE |
Research funded by EVAg, Published by EVAg end-user |
Aug 2021 |
A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020 |
Virus Genes |
Research funded by EVAg, Published by EVAg partner |
Aug 2021 |
The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues |
Viruses |
Research funded by EVAg, Published by EVAg end-user |
Aug 2021 |
Amaryllidaceae Alkaloid Cherylline Inhibits the Replication of Dengue and Zika Viruses |
Antimicrobial Agents and Chemotherapy |
Research funded by EVAg, Published by EVAg end-user |
Aug 2021 |
The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses |
Microorganisms |
Research funded by EVAg, Published by EVAg end-user |
Aug 2021 |
Real-Life Head-to-Head Comparison of Performance of Two High-Throughput Automated Assays for the Detection of SARS-CoV-2 RNA in Nasopharyngeal Swabs |
The Journal of Molecular Diagnostics |
Research funded by EVAg, Published by EVAg partner |
Aug 2021 |
Decay of infectious SARS-CoV-2 and surrogates in aquatic environments |
Water Research |
Research funded by EVAg, Published by EVAg end-user |
Jul 2021 |
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 |
Annals of Internal Medicine |
Research funded by EVAg, Published by EVAg end-user |
Jul 2021 |
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned |
Clinical Microbiology and Infection |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
Jul 2021 |
Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: A pilot project |
Journal of Infection |
Research funded by EVAg, Published by EVAg end-user |
Jul 2021 |
Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals |
Transboundary and Emerging Diseases |
Research funded by EVAg, Published by EVAg partner |
Jul 2021 |
Complete Genome Sequence of African Swine Fever Virus Isolated from a Domestic Pig in Timor-Leste, 2019 |
Microbiology Resource Announcements |
Research funded by EVAg, Published by EVAg partner |
Jun 2021 |
COVID-19 laboratory preparedness and response in the Americas Region: Lessons learned |
PLoS ONE |
Research funded by EVAg, Published by EVAg end-user |
Jun 2021 |
Nonsterile immunity to cryptosporidiosis in infants is associated with mucosal IgA against the sporozoite and protection from malnutrition |
PLoS Pathogens |
Research funded by EVAg, Published by EVAg end-user |
Jun 2021 |
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19 |
PLoS ONE |
Research funded by EVAg, Published by EVAg end-user |
Jun 2021 |
Endonuclease-based genotyping of the RBM, a first-line method for the surveillance of emergence or evolution of SARS-CoV-2 Variants |
|
Research funded by EVAg, Published by EVAg partner |
Jun 2021 |
Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA |
European Journal of Clinical Microbiology & Infectious Diseases |
Research funded by EVAg, Published by EVAg end-user |
Jun 2021 |
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay |
Journal of Clinical Virology |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
Jun 2021 |
Detection and complete genome sequence of a divergent isolate of cucumber fruit mottle mosaic virus on Coccinia grandis in Sudan |
Archives of Virology |
Research funded by EVAg, Published by EVAg end-user |
Jun 2021 |
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection |
Antiviral Research |
Research funded by EVAg, Published by EVAg partner |
Jun 2021 |
Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein |
Water Research |
Research funded by EVAg, Published by EVAg end-user |
May 2021 |
Validation of Inactivation Methods for Arenaviruses |
Viruses |
Research funded by EVAg, Published by EVAg partner |
May 2021 |
Whole-genome sequencing and phylogenetic analysis of rabies viruses from Jordan |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Published by EVAg partner |
May 2021 |
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates |
Science Translational Medicine |
Research funded by EVAg, Published by EVAg end-user |
May 2021 |
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures |
American Journal of Physiology-Lung Cellular and Molecular Physiology |
Research funded by EVAg, Published by EVAg end-user |
May 2021 |
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies |
Cell Reports Medicine |
Research funded by EVAg, Published by EVAg partner |
Apr 2021 |
Biological Cloth Face Coverings—The Reduction of SARS-CoV-2 and Influenza (H1N1) Infectivity by Viruferrin™ Treatment |
Materials |
Research funded by EVAg, Published by EVAg end-user |
Apr 2021 |
Macrolides May Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Entry into Cells: A Quantitative Structure Activity Relationship Study and Experimental Validation |
Journal of Chemical Information and Modeling |
Research funded by EVAg, Published by EVAg end-user |
Apr 2021 |
Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Apr 2021 |
SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus |
Viruses |
Research funded by EVAg, Published by EVAg partner |
Apr 2021 |
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods |
Pharmaceuticals |
Research funded by EVAg, Published by EVAg end-user |